Inventiva SA Sustainability Reports

Inventiva S.A. is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies. Its pipeline primarily targets treatments for metabolic dysfunction-associated steatohepatitis (MASH/NASH) and other diseases with significant unmet medical need.

Sector: Manufacturing

Country: France

Exchange: Euronext Paris

LEI: 969500I9Y690B3FZW590

FIGI: BBG00DGY8YK4

7 reports from 2016 to 2025

• Inventiva SA 2025 Universal Registration Document Including Annual Financial Report
• Inventiva SA 2024 Universal Registration Document Including the Annual Financial Report
• Inventiva SA 2020 Code of Business Conduct and Ethics
• Inventiva SA 2019 Annual Financial Report
• Inventiva SA 2018 Registration Document Including the Annual Financial Report